Delivery Order SPE2DB20D3103-SPE2DB24FL7A6
Award Date 11/29/23
Potential Completion Date 11/30/23
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,938.77 firm fixed-price contract is for the delivery of PIMECROLIMUS 1% CREAM 100GM, with a completion date of May 20, 2025. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,029.03 firm fixed price contract is for the delivery of PIMECROLIMUS 1% CREAM 100GM and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pimecrolimus 1% Cream in 60-gram tubes, with a ceiling value of $1,759.49 and a completion date of March 14, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,124.57, is for the provision of PIMECROLIMUS 1% CREAM 100GM, a pharmaceutical product. The contract has a period of performance through November 26, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Pimecrolimus 1% Cream, a prescription medication, with a total ceiling value of $6,177.35 and a period of performance through January 24, 2025. The contract is an open competition, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pimecrolimus 1% Cream, a medication, with a ceiling value of $1,030.62 and a period of performance through June 26, 2025. The contract is a firm-fixed-price type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 100-gram quantities, with a ceiling value of $1,704.94. This contract, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizes firm fixed-price pricing and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- This is a $8,995.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pimecrolimus 1% cream. The contract has an ultimate completion date of July 15, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of PIMECROLIMUS CREAM. The contract has a ceiling value of $1,849.89 and an ultimate completion date of February 22, 2024. Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, is the prime contractor. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pimecrolimus 1% Cream, a prescription topical medication, with a ceiling value of $4,123.95 and a period of performance through April 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL7A6Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PIMECROLIMUS 1% CREAM 100GM, with a ceiling value of $1,242.93 and a completion date of November 30, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 5/12/25, 9:57 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/29/23 |